2020 NYT No, These Medicines Cannot Cure Coronavirus As psychiatrists, we are worried about the shocking increase in people self-medicating with unsafe drugs. banned How South Africa banned skin-lightening creams In 1990, South Africa became the first country in the world to ban skin-lightening creams containing the chemical compound hydroquinone. brazil Chloroquine Study Halted Over Risk of Fatal Heart Complications A small study in Brazil was halted early for safety reasons after coronavirus patients taking a higher dose of chloroquine developed irregular heart rates that increased their risk of a potentially fatal heart arrhythmia. demons Sex with demons Sex-with-demons "A Doctor Promoted by Trump Is Also Concerned About the Side Effects of Having Sex With Demons" Demons-illness "Trump retweeted a video with false covid-19 claims. One doctor in it has said demons cause illnesses." Demon-sperm Viral sensation Dr. Stella Immanuel says Jesus will destroy Facebook if her COVID video doesn’t go back up Things got really weird in late July 2020 when President Trump retweeted a video from a made up group called "Frontline doctors" (despite there being no proof these doctors are anywhere near the COVID-19 front lines) that endorsed Hydroxychloroquine. One of these doctors claimed illness was caused by demons and is concerned with the side effects of sex with demons and aliens. You can't make this stuff up. french The French Connection: Trump Family Trusts Are Invested in Hydroxychloroquine Maker Retailers most at risk of closing for good Biden blasts Trump Jr.'s 'sick' joke President Donald Trump and his allies in the conservative media sphere have repeatedly pushed the health benefits of anti-malarial drug hydroxychloroquine for patients who have contracted the novel Coronavirus (COVID-19). While scientific opinion on the efficacy of the drug for treatment of the COVID-19 disease is necessarily shy of consensus, Trump himself has a personal financial interest in a French drugmaker that produces a brand-name version of the medication.

funding Pharma-Funded Group Tied to a Top Trump Donor Is Promoting Malaria Drug to the President Founded by one of Trump's top donors, the Job Creators Network has been pushing Trump to approve the use of hydroxychloroquine for treating COVID-19. It’s unclear why Trump has been such a proponent of hydroxychloroquine, but one answer may lie with the millions of dollars in political support he has received from the founder of a pharmaceutical industry-funded group that has been pushing him to make the drug available. The Job Creators Network was founded in 2011 by billionaire Home Depot co-founder Bernard Marcus, a major GOP donor who spent more than $7 million through outside groups to help elect Trump in 2016. Marcus has said that he plans to spend part of his fortune to help re-elect Trump in 2020. Job Creators Network has been funded by Pharmaceutical Research and Manufacturers of America (PhRMA), a drug industry trade that counts among its members leading hydroxychloroquine makers Novartis, Teva Pharmaceuticals, and Bayer. According to tax documents, PhRMA donated $500,000 to Job Creators Network in 2017. Novartis, Teva, and Bayer have all committed to providing millions of doses of hydroxychloroquine for clinical testing, and the companies potentially stand to profit if the drug becomes adopted as a common coronavirus treatment. navarro Navarro drags Fauci feud into the public White House trade adviser Peter Navarro on Monday questioned the experience and medical judgment of Dr. Anthony Fauci — dragging his reported dispute with the nation's top infectious disease expert out of the Situation Room and onto cable news. In a fiery interview on CNN, Navarro appeared to confirm media accounts of his altercation with Fauci, director of the National Institute of Allergy and Infectious Diseases, during a meeting of the White House coronavirus task force Saturday. The clash focused on the efficacy of hydroxychloroquine, a controversial potential treatment for the coronavirus that President Donald Trump has promoted despite limited clinical evidence. he president and his allies, however, have continued to champion the decades-old malaria drug as a possible medical remedy for Covid-19, the disease caused by the novel coronavirus, despite repeated warnings from senior health officials that the medicine requires further trials. political The reasons to push Chloroquines are political not scientific. Behind the scenes: This drama erupted into an epic Situation Room showdown. Trump's coronavirus task force gathered in the White House Situation Room on Saturday at about 1:30pm, according to four sources familiar with the conversation. Vice President Mike Pence sat at the head of the table. Numerous government officials were at the table, including Fauci, coronavirus response coordinator Deborah Birx, Jared Kushner, acting Homeland Security Secretary Chad Wolf, and Commissioner of Food and Drugs Stephen Hahn. Behind them sat staff, including Peter Navarro, tapped by Trump to compel private companies to meet the government's coronavirus needs under the Defense Production Act. Navarro said "the studies that he's seen, I believe they're mostly overseas, show 'clear therapeutic efficacy,'" said a source familiar with the conversation. "Those are the exact words out of his mouth." Navarro's comments set off a heated exchange about how the Trump administration and the president ought to talk about the malaria drug, which Fauci and other public health officials stress is unproven to combat COVID-19. Fauci pushed back against Navarro, saying that there was only anecdotal evidence that hydroxychloroquine works against the coronavirus. Researchers have said studies out of France and China are inadequate because they did not include control groups. Fauci and others have said much more data is needed to prove that hydroxychloroquine is effective against the coronavirus. trump "Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine." If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine. The professional organization that published a positive French study cited by Mr. Trump’s allies changed its mind in recent days. The International Society of Antimicrobial Chemotherapy said, “The article does not meet the society’s expected standard.” Some hospitals in Sweden stopped providing hydroxychloroquine to treat the coronavirus after reports of adverse side effects, according to Swedish news media. worse Malaria Drug Chloroquine No Better Than Regular Coronavirus Care, Study Finds Hydroxychloroquine, a medicine for malaria that President Donald Trump has touted as a treatment for coronavirus, was no more effective than conventional care, a small study found. The report published by the Journal of Zhejiang University in China showed that patients who got the medicine didn’t fight off the new coronavirus more often than those who did not get the medicine.